Slovenian drug firm Krka's Q1 net profit rises 29.5 pct
LJUBLJANA, May 14 (Reuters) - Slovenian pharmaceutical
company Krka KRKG.LJ posted a 29.5 percent rise in
first-quarter net profit to 55.1 million euros, the company said
on Thursday.
Sales fell to 289.3 million euros in the January-March
period, from 298 million in the same quarter of 2014, it said.
(Reporting By Marja Novak; Editing by Pravin Char)
((Marja.Novak@thomsonreuters.com; +386-1-5058805; Reuters
Messaging: marja.novak.thomsonreuters.com@reuters.net))
Keywords: KRKA PROFIT/
Recent news on Krka dd Novo Mesto
See all newsMedia: Slovenia's Krka eyeing promoter stake in India's Unichem - ET
Brief: Krka dd Novo Mesto Says Q1 Net Profit EUR 86.5 Mln
Slovenia's Krka Jan-June net profit rises 15%
Slovenian drugmaker Krka says demand higher, virus impact unpredictable
Slovenia's Krka revises up 2019 profit, says virus impact unpredictable